Skip to main content
Premium Trial:

Request an Annual Quote

DxTerity Lands $7.5M in Debt Financing

NEW YORK (GenomeWeb) – DxTerity Diagnostics announced on Tuesday that it has arranged to receive up to $7.5 million in term debt financing from SWK Funding, a subsidiary of SWK Holdings.

The firm said it will use the proceeds toward the commercialization of its DxDirect genomics testing platform and DxCollect MicroCollection Device (MCD).

The firm's proprietary chemistry, DxDirect, enables multiplexed genomic testing directly from the patient sample. The DxCollect MCD allows for the stabilization and transport of blood RNA collected from a finger or heel prick.

"This funding allows DxTerity to aggressively pursue the commercialization of its technology, including [the] expansion of DxDirect to next-generation sequencing systems, and [the use of] DxCollect MCD to power direct-to-patient clinical studies for accelerated validation of molecular diagnostic assays," DxTerity CEO Bob Terbrueggen said in a statement.

In February, a partnership between DxTerity and Duke University received $10.4 million from the US Department of Health and Human Services Biomedical Advanced Research and Development Authority to continue developing a genetic test for radiation exposure.

 

 

The Scan

And a Fourth?

A fourth dose of the Pfizer-BioNTech SARS-CoV-2 vaccine in an Israeli study increased antibody levels but did not prevent Omicron variant infections, according to the Financial Times.

For Better Science Software

A virtual institute funded by former Google CEO Eric Schmidt's philanthropy aims to lure software engineers to academia, Science reports.

Recommendation Explanations

The New York Times writes that the US Centers for Disease Control and Prevention is straining to both make and explain decisions based on limited information.

Genome Research Papers on De Novo Mutation Rates, Polyploid Genotyping, Oncogene Epigenomic Translocation

In Genome Research this week: de novo mutations rates in hemoglobin subunits, analysis of variant calling methods for polyploid plants, and more.